Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M6OW
|
|||
| Former ID |
DPR000170
|
|||
| Drug Name |
ANAVEX 1007
|
|||
| Indication | Melanoma [ICD-11: 2C30] | Preclinical | [1] | |
| Pancreatic cancer [ICD-11: 2C10] | Preclinical | [1] | ||
| Prostate cancer [ICD-11: 2C82.0] | Preclinical | [1] | ||
| Company |
Anavex
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Agonist | [1] |
| Sigma intracellular receptor 2 (TMEM97) | Target Info | Agonist | [1] | |
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2011 Pipeline of Anavex. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.